<DOC>
	<DOCNO>NCT00477217</DOCNO>
	<brief_summary>This study ass safety efficacy zoledronic acid patient present spontaneous osteonecrosis knee .</brief_summary>
	<brief_title>Zoledronic Acid Treatment Spontaneous Osteonecrosis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Adults 4085 year age Diagnosis painful osteonecrosis knee within last month . Intravenous ( iv ) bisphosphonates within last 2 year . Abnormal thyroid , kidney liver function . Abnormal blood calcium alkaline phosphatase level . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Osteonecrosis</keyword>
	<keyword>zoledronic acid</keyword>
	<keyword>knee</keyword>
</DOC>